Due: June 11, 2024 The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for the Research Units (RUs), one of the two scientific components of the Pancreatic Cancer Detection Consortium (PCDC), to Read More
Due: May 20, 2024 The purpose of this Funding Opportunity Announcement (FOA) is to address topics related to the use of digital health technologies (DHTs) for remote data acquisition in clinical investigations to support drug Read More
Due: May 14, 2024 The 2023 update to theNational Artificial Intelligence Research and Development Strategic Plan,informed byvisioning activities in the scientific communityas well asinteraction with the public, identifies as its first strategic objective the need Read More
Due: May 10, 2024 The Complete Streets Artificial Intelligence Initiative is a multi-phase effort to develop a suite of powerful new decision-support tools for state, local, and tribal transportation agencies that assist in the siting, Read More
Due: May 8, 2024 The DOE SC program in Basic Energy Sciences (BES) announces a re-competition of the Energy Frontier Research Center (EFRC) program and encourages both new and renewal applications. Applications from multi-disciplinary teams Read More
Due: July 28, 2024 The purpose of this funding opportunity is to develop artificial intelligence tools and experimental assays to identify new pharmacotherapeutics with lower toxicity and higher efficacy for substance use disorders (SUD) Areas Read More
Anticipated Release Date: Q2FY24 Develop a microphysiological system that realistically mimics human physiological responses to threat exposures for rapid discovery of diagnostic biomarkers. Responding to this opportunity requires membership in the Medical CBRN Defense Consortium. This Consortium Read More
Anticipated Release Date: Q1FY25 FDA approval of a multi-drug autoinjector to reduce logistical burden on the warfighter and increase survivability Responding to this opportunity requires membership in the Medical CBRN Defense Consortium. This Consortium releases numerous solicitations Read More
Anticipated Release Date: Q1FY24 OR Q2FY24 Small Molecule Therapeutics Responding to this opportunity requires membership in the Medical CBRN Defense Consortium. This Consortium releases numerous solicitations throughout the year, so even if this opportunity may not end Read More
Anticipated Release Date: Q3FY24 Develop a diagnostic prototype strip, compatible with the ChemDx device, able to diagnose opioid exposure. Additional test strips able to differentiate between bacterial vs. viral infection, pre-symptomatic, contagiousness, or disease severity may Read More
NTA is operated by the 501c(3) non-profit Advanced Technology International (ATI). National Technology Alliance (NTA) © 2024 - All rights reserved.